TETLOW SHARON 4
4 · DICE Therapeutics, Inc. · Filed Jun 8, 2022
Insider Transaction Report
Form 4
TETLOW SHARON
Director
Transactions
- Award
Stock Option (right to buy Common Stock)
2022-06-07+21,250→ 21,250 totalExercise: $14.98Exp: 2032-06-06→ Common Stock (21,250 underlying)
Footnotes (1)
- [F1]The option vests on the earlier to occur of: (i) the one-year anniversary of the grant date and (ii) the subsequent annual meeting of the Registrant's stockholders, in each case, subject to the Reporting Holder's continued service to the Registrant.